FORATOL
Natural health product licensed in Canada
- Licence holder
- Bio-Actif Inc.
- NPN or DIN-HM
- 00724181
- Status
- Active licence
- Licence date
- 27 November 2007
- Revision date
- 20 September 2020
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- DIN de transition
If this product were sold in France
- Conditions légales
Medicago sativa L.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Bos taurus Source : Bile | 100 mg | Not calculated |
| Bitartrate de choline Source : Synthétique | 100 mg | Not calculated |
| Cynara scolymus Source : Feuille séchée Extraction ratio : 4:1 Dry plant equivalent : 100 mg | 25 mg | Not calculated |
| Medicago sativa Source : Parties aériennes | 5 mg | Not calculated |
Non-medicinal ingredients
PEG (polyéthylèneglycol), Dextrose, monohydrate, Cellulose, carboxyméthyl éther, FD & C bleu #1, Stéarate de magnésium, Lactose Monohydrate, Maltodextrine, Hydroxypropyl methylcellulose, Dioxyde de titane, cellulose, FD & C Rouge # 40, Jaune D & C No. 10, Monooléate de polyoxyéthylène (20) sorbitan, Gel de silice colloïdal, Povidone, Lécithine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Comprimé | minimum: 3 Tous les jours |
Uses authorised in Canada
Utilisé traditionnellement en phytothérapie pour soigner la digestion difficile et pour aider à stimuler la sécrétion et l'écoulement de la bile.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consulter un praticien de soins de santé avant d'en faire l'usage si vous avez des calculs biliaires, souffrez de troubles du foie ou des reins. Consulter un praticien de soins de santé avant d'en faire l'usage si vous prenez des anticoagulants, suivez un traitement hormonal substitutif (THS) ou prenez des contraceptifs. Consulter un praticien de soins de santé si les symptômes persistent ou s'aggravent.
Source
Official Health Canada record, licence 00724181
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2020. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.